Literature DB >> 11316971

The pathophysiology, diagnosis and therapy of the transurethral resection of the prostate syndrome.

M Balzarro1, V Ficarra, A Bartoloni, C Tallarigo, G Malossini.   

Abstract

In this article, the authors analyze a syndrome first described by Creevy in the 1940s, which may occur during a transurethral resection of the prostate (TURP). The syndrome is characterized by cardiocirculatory and neurological problems due to rapid changes in intravascular volume and plasma solute concentrations caused by excess irrigating fluid absorption. This article reviews the available literature and reports on the experience of our clinic, a specialist department in the physiopathology, diagnosis, therapy and prevention of TURP syndrome.

Entities:  

Mesh:

Year:  2001        PMID: 11316971     DOI: 10.1159/000056589

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  4 in total

1.  Comparison of deep biopsy tissue damage from transurethral resection of bladder tumors between bipolar and monopolar devices.

Authors:  So Jun Yang; Phil Hyun Song; Hyun Tae Kim
Journal:  Korean J Urol       Date:  2011-06-17

2.  Severe hypocalcemia caused by absorption of sorbitol-mannitol solution during hysteroscopy.

Authors:  Guie Yong Lee; Jong In Han; Hyun Joo Heo
Journal:  J Korean Med Sci       Date:  2009-06-18       Impact factor: 2.153

3.  Bladder injury secondary to obturator reflex is more common with plasmakinetic transurethral resection than monopolar transurethral resection of bladder cancer.

Authors:  Kutan Ozer; Mustafa Ozan Horsanali; Sacit Nuri Gorgel; Emin Ozbek
Journal:  Cent European J Urol       Date:  2015-09-26

4.  Comparing the short - term outcomes and complications of monopolar and bipolar transurethral resection of bladder tumors in patients with coronary artery disese: a prospective, randomized, controlled study.

Authors:  Deniz Bolat; Bulent Gunlusoy; Ozgu Aydogdu; Mehmet Erhan Aydin; Cetin Dincel
Journal:  Int Braz J Urol       Date:  2018 Jul-Aug       Impact factor: 1.541

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.